For instance, one study found that 26% of PDAC profiles had actionable molecular alterations, leading to a notable improvement in survival rates, with a hazard ratio of 0.42 and a highly significant p -value of 0.0004 [ 10 ].
← all excerpts
Targeted Therapies in Pancreatic Cancer: A New Era of Precision Medicine.
1
—
—